| Dr Felix T Cabrera, MD | |
|
655 Harmon Loop Rd Ste 108, Dededo, GU 96929-6544 | |
| (671) 633-4447 | |
| (671) 633-4452 |
| Full Name | Dr Felix T Cabrera |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Location | 655 Harmon Loop Rd Ste 108, Dededo, Guam |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164697546 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | M-1709 (Guam) | Secondary |
| 208M00000X | Hospitalist | M-1709 (Guam) | Primary |
| Entity Name | Guam Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366519027 PECOS PAC ID: 5890781694 Enrollment ID: O20040426000038 |
News Archive
Current HIV treatments need to be taken for life by those infected as antiretroviral therapy is unable to eliminate viral reservoirs lurking in immune cells. Institut Pasteur scientists have identified the characteristics of CD4 T lymphocytes that are preferentially infected by the virus - it is their metabolic (or energy-producing) activity1 that enables the virus to multiply.
Tibotec Pharmaceuticals today announced that it has granted multiple non-exclusive licenses to generic manufacturers including Hetero Drugs Limited, Matrix Laboratories Limited (a Mylan company) of India and Aspen Pharmacare of South Africa to manufacture, market and distribute the investigational non-nucleoside reverse transcriptase inhibitor rilpivirine hydrochloride (TMC278), pending its approval for use with other antiretroviral agents in the treatment of treatment-naive HIV-1 infected adults.
A programmable medical robot has been developed that could be implanted into an animal and help increase the size of the tube-like organs by pulling on them appropriately. The robot can stimulate tissue growth. This new robotic system was unveiled in an article published in the Science Robotics.
Nice guys do finish last at least when it comes to procreation according to a study from The University of Texas at San Antonio that answers the question of why women choose bad boys.
› Verified 1 days ago
| Entity Name | Guam Healthcare Development Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326447939 PECOS PAC ID: 9234351776 Enrollment ID: O20150326000266 |
News Archive
Current HIV treatments need to be taken for life by those infected as antiretroviral therapy is unable to eliminate viral reservoirs lurking in immune cells. Institut Pasteur scientists have identified the characteristics of CD4 T lymphocytes that are preferentially infected by the virus - it is their metabolic (or energy-producing) activity1 that enables the virus to multiply.
Tibotec Pharmaceuticals today announced that it has granted multiple non-exclusive licenses to generic manufacturers including Hetero Drugs Limited, Matrix Laboratories Limited (a Mylan company) of India and Aspen Pharmacare of South Africa to manufacture, market and distribute the investigational non-nucleoside reverse transcriptase inhibitor rilpivirine hydrochloride (TMC278), pending its approval for use with other antiretroviral agents in the treatment of treatment-naive HIV-1 infected adults.
A programmable medical robot has been developed that could be implanted into an animal and help increase the size of the tube-like organs by pulling on them appropriately. The robot can stimulate tissue growth. This new robotic system was unveiled in an article published in the Science Robotics.
Nice guys do finish last at least when it comes to procreation according to a study from The University of Texas at San Antonio that answers the question of why women choose bad boys.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Felix T Cabrera, MD 655 Harmon Loop Rd Ste 108, Dededo, GU 96929-6544 Ph: (671) 633-4447 | Dr Felix T Cabrera, MD 655 Harmon Loop Rd Ste 108, Dededo, GU 96929-6544 Ph: (671) 633-4447 |
News Archive
Current HIV treatments need to be taken for life by those infected as antiretroviral therapy is unable to eliminate viral reservoirs lurking in immune cells. Institut Pasteur scientists have identified the characteristics of CD4 T lymphocytes that are preferentially infected by the virus - it is their metabolic (or energy-producing) activity1 that enables the virus to multiply.
Tibotec Pharmaceuticals today announced that it has granted multiple non-exclusive licenses to generic manufacturers including Hetero Drugs Limited, Matrix Laboratories Limited (a Mylan company) of India and Aspen Pharmacare of South Africa to manufacture, market and distribute the investigational non-nucleoside reverse transcriptase inhibitor rilpivirine hydrochloride (TMC278), pending its approval for use with other antiretroviral agents in the treatment of treatment-naive HIV-1 infected adults.
A programmable medical robot has been developed that could be implanted into an animal and help increase the size of the tube-like organs by pulling on them appropriately. The robot can stimulate tissue growth. This new robotic system was unveiled in an article published in the Science Robotics.
Nice guys do finish last at least when it comes to procreation according to a study from The University of Texas at San Antonio that answers the question of why women choose bad boys.
› Verified 1 days ago